Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

BACKGROUND AND AIMS: Immune checkpoint inhibitors (ICI) are increasingly used in cancer therapy. Elevated liver enzymes frequently occur in patients treated with ICI but evaluation is poorly described. We sought to better understand causes of liver enzyme elevation, investigation and management. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, Morven, Iafolla, Marco, Kanjanapan, Yada, Cerocchi, Orlando, Butler, Marcus, Siu, Lillian L., Bedard, Philippe L., Ross, Kendra, Hansen, Bettina, Spreafico, Anna, Feld, Jordan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195413/
https://www.ncbi.nlm.nih.gov/pubmed/34115819
http://dx.doi.org/10.1371/journal.pone.0253070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195413/
https://www.ncbi.nlm.nih.gov/pubmed/34115819
http://dx.doi.org/10.1371/journal.pone.0253070

Ejemplares similares